Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13060300 | 0.98 | — | — | |
| SCHEMBL13060260 | 0.98 | — | — | |
| SCHEMBL13060310 | 0.94 | ABCG2 (0.34) | ABCG2PTGDR2 | |
| SCHEMBL13060511 | 0.94 | ABCG2 (0.34) | ABCG2PTGDR2 | |
| SCHEMBL22987047 | 0.92 | SLC6A4 (0.31) | ABCG2PTGDR2 | |
| SCHEMBL13060252 | 0.92 | SLC6A4 (0.31) | ABCG2PTGDR2 | |
| SCHEMBL13060295 | 0.91 | — | — | |
| SCHEMBL13060521 | 0.87 | KCNN4 (0.37) | ABCG2 | |
| SCHEMBL13060301 | 0.87 | KCNN4 (0.37) | ABCG2 | |
| SCHEMBL13004382 | 0.87 | KCNN4 (0.37) | ABCG2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7846558-B2 | Blue light emitting compound and organic electroluminescent device using the same | SFC CO., LTD. (KR) | 2010-12-07 | — | — | US | disclosed |
| US-20080203905-A1 | Blue light emitting compound and organic electroluminescent device using the same | SFC CO., LTD. (KR) | 2008-08-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080203905-A1 | Blue light emitting compound and organic electroluminescent device using the same | TYR, CYBA, CRY2 | ABCG2 2182/4885PTGDR2 3961/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.